Regarding metastatic PCa, both RASSF1A and GSTP1 exhibited pathological DNA methylation levels in all PCa patients, supporting beneficial application of this epigenetic biomarker analysis for cancer therapy control and early detection of metastasis. Here, RASSF1 is linked to cancer.